| Pliva d.o.o. | |
| Type: | Subsidiary |
| Industry: | Pharmaceutical industry |
| Parent: | Teva Pharmaceuticals |
| Location: | Zagreb, Croatia |
| Key People: | Mihael Furjan (CEO) |
| Num Employees: | 1,700 |
| Products: | Generic drugs |
| Revenue: | $1.174 billion (2005) |
| Net Income: | $0.336 billion (2005) |
| Footnotes: | [1] |
Pliva d.o.o. is a pharmaceutical company based in Zagreb, Croatia that primarily manufactures and sells generic drugs. It is a subsidiary of Teva Pharmaceuticals.
Pliva is one of the world's largest producers of generic Adderall.
The company was founded in 1921.[1]
A team of Pliva's researchers, Gabrijela Kobrehel, Gorjana Radobolja-Lazarevski and led by Dr. Slobodan Đokić, discovered azithromycin in 1980.
In June 2002, the company acquired Sidmak for $152.9 million.[2]
Also in June 2002, Zeljko Peric, the chief financial officer of the company, resigned.[3]
In May 2004, the company received approval from the Food and Drug Administration to sell trospium chloride.[4]
In June 2005, the company received approval to sell a generic version of erythropoietin in Croatia.[5]
In November 2005, the company received approval from the Food and Drug Administration to sell a generic version of Azithromycin,[6] Citalopram,[7] and Ondansetron.[8]
In October 2006, Barr Pharmaceuticals acquired Pliva.[9]
On December 23, 2008, Barr Pharmaceuticals was acquired by Teva Pharmaceuticals and the company became part of Teva Active Pharmaceutical Ingredients (TAPI).[10]